Scholarlink

<p>Type 2 diabetes is a significant global health problem caused by impaired insulin secretion and insulin resistance in body tissues. This study aimed to identify bioactive compounds in <i>Homotrigona apicalis</i> propolis that have α-glucosidase inhibitory potential, demonstrating anti-diabetic properties. Molecular docking was used to study the interaction mechanism between active compounds in <i>H. apicalis</i> propolis and α-glucosidase. Software such as AutoDock, and PyRx were used to predict pharmacokinetic parameters, evaluate toxicity and perform docking simulations. The findings suggest that bioactive compounds in <i>H. apicalis</i> propolis have strong potential as anti-diabetic agents. Compounds such as alpha-amyrin, DM ganodaric acid and rotlerin exhibited higher binding affinity to α-glucosidase than acarbose, with lower binding energy. Docking analysis was supported by an RMSD value of 1.904&#xa0;Å and rottalerin showed a similar mechanism of action as acarbose. These results indicate that <i>H. apicalis</i> propolis compounds have significant potential as antidiabetic agents and provide important insights for the development of natural ingredient-based antidiabetic therapies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Identification of Homotrigona apicalis propolis compounds as α-glucosidase inhibitors with antidiabetic activity in a molecular docking approach

  • 期刊论文

  • 发表日期：

    2025年11月10日

查看全文
  • Paula Mariana Kustiawan,
  • Kafka Navisa Suwarno,
  • Vera Herliani Pratiwi,
  • Khalish Arsy Al Khairy Siregar,
  • Nunung Herlina,
  • Ghozali Ghozali,
  • Putri Hawa Syaifie,
  • Etik Mardliyanti

摘要

Type 2 diabetes is a significant global health problem caused by impaired insulin secretion and insulin resistance in body tissues. This study aimed to identify bioactive compounds in Homotrigona apicalis propolis that have α-glucosidase inhibitory potential, demonstrating anti-diabetic properties. Molecular docking was used to study the interaction mechanism between active compounds in H. apicalis propolis and α-glucosidase. Software such as AutoDock, and PyRx were used to predict pharmacokinetic parameters, evaluate toxicity and perform docking simulations. The findings suggest that bioactive compounds in H. apicalis propolis have strong potential as anti-diabetic agents. Compounds such as alpha-amyrin, DM ganodaric acid and rotlerin exhibited higher binding affinity to α-glucosidase than acarbose, with lower binding energy. Docking analysis was supported by an RMSD value of 1.904 Å and rottalerin showed a similar mechanism of action as acarbose. These results indicate that H. apicalis propolis compounds have significant potential as antidiabetic agents and provide important insights for the development of natural ingredient-based antidiabetic therapies.